HealthInvest showcased ASX-listed healthcare companies where scientific innovation, commercial opportunity and patient outcomes align.

The new financial year is approaching, and I think these three ASX shares could be worth buying before FY27 begins.

Eli Lilly and Co. has signed another billion-dollar deal, this time with Boston-based Ascidian Therapeutics Inc., a company that is barely four years old and one that is focused on treating human ...

If your device’s sound is too low or the Microphone is not working in Windows 11/10, refer to the steps in the post to troubleshoot the issue. The problem can occur due to improper peripheral ...

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, ...